Bhubaneswar, June 20 -- https://images.odishatv.in/uploadimage/library/16_9/16_9_0/recent_photo_1750408265.webp
The World Health Organization (WHO) has welcomed the recent approval by the United States Food and Drug Administration (FDA) of injectable lenacapavir for HIV prevention. The regulatory milestone marks a significant advancement in global HIV prevention strategies and follows promising 2024 results from the PURPOSE 1 and PURPOSE 2 trials.
The trials demonstrated lenacapavir's safety and efficacy across diverse populations and settings. Notably, the drug requires administration only twice a year, offering sustained protection and adding to the expanding array of HIV prevention options.
Currently, WHO recommends oral PrEP, the dap...